MSON: Here's a little med tech equipment manufacturer that I once held and made some money trading. Their Sonablate HIFU system works well and there was always the buzz (back when I was trading it) that they would be entering the cancer sector with evidence-based use of HIFU to go after tumors. After waiting for some substantive announcements for 4 or 5 quarters, I moved on and haven't kept up with it since.
A quick perusal of their website suggests to me that they are playing the same game. MSON might be a decent trading stock (particularly if they have a decent quarter here and there, boosting their profile) that I would trade out of before they settle back into a low price range. If you were in at 90 cents, I would be out by $3. I don't think you'll see $5-7, and certainly don't think they'll get bought out.
JM2C,
aj
